US Patent 11304942 Parenteral unit dosage form of dihydroergotamine
Patent 11304942 was granted and assigned to Sun Pharmaceutical on April, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
December 6, 2019
Date of Patent
April 19, 2022
Patent Application Number
16705435
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11304942 Parenteral unit dosage form of dihydroergotamine
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.